Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies

Abstract Introduction Cancer diagnosis influences the choices that patients make regarding current and future labor market activity. These choices have implications for governments based on resulting changes in taxes paid and benefits received. In this analysis we explore how human growth receptor 2...

詳細記述

書誌詳細

主要な著者:	Svenn Alexander Kommandantvold, Nikos Kotsopoulos, Isabel Monteiro, Ana Ladeiras, Andrew Hogan, Felipe Barboza Magalhães de Araujo, Mark P. Connolly
フォーマット:	Artigo
言語:	Inglês
出版事項:	Adis, Springer Healthcare 2024-02-01
シリーズ:	Oncology and Therapy
主題:	Fiscal analysis Cost–benefit analysis HER2-positive breast cancer Life course modeling Cancer survival
オンライン･アクセス:	https://doi.org/10.1007/s40487-024-00264-9
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!